Cullinan Oncology Inc

NASDAQ:CGEM

11.47

+0.91 (+8.62%)

Mergers / Acquisitions

Cullinan And Taiho To Jointly Develop And Commercialize Cln-081/Tas6417 And Taiho's Acquisition Of Cullinan Pearl

Published: 05/12/2022 06:14 GMT

CGEM

Cullinan Oncology Inc (CGEM) - Cullinan Oncology and Taiho Pharmaceutical Announce Strategic Collaboration to Jointly Develop and Commercialize Cln-081/tas6417 and Taiho's Acquisition of Cullinan Pearl.